161 related articles for article (PubMed ID: 23190918)
1. Effect of panretinal photocoagulation treatment on vision-related quality of life of patients with proliferative diabetic retinopathy.
Tsilimbaris MK; Kontadakis GA; Tsika C; Papageorgiou D; Charoniti M
Retina; 2013 Apr; 33(4):756-61. PubMed ID: 23190918
[TBL] [Abstract][Full Text] [Related]
2. Effect of laser photocoagulation treatment for diabetic macular oedema on patient's vision-related quality of life.
Tranos PG; Topouzis F; Stangos NT; Dimitrakos S; Economidis P; Harris M; Coleman AL
Curr Eye Res; 2004 Jul; 29(1):41-9. PubMed ID: 15370366
[TBL] [Abstract][Full Text] [Related]
3. Vision-related quality of life and visual function following vitrectomy for proliferative diabetic retinopathy.
Okamoto F; Okamoto Y; Fukuda S; Hiraoka T; Oshika T
Am J Ophthalmol; 2008 Jun; 145(6):1031-1036. PubMed ID: 18400203
[TBL] [Abstract][Full Text] [Related]
4. Effect of pan-retinal photocoagulation treatment on vision-related quality of life of patients with proliferative diabetic retinopathy.
Fenwick EK; Lamoureux EL
Retina; 2013; 33(7):1479. PubMed ID: 23967449
[No Abstract] [Full Text] [Related]
5. Vision-related quality of life and visual function after vitrectomy for various vitreoretinal disorders.
Okamoto F; Okamoto Y; Fukuda S; Hiraoka T; Oshika T
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):744-51. PubMed ID: 19815727
[TBL] [Abstract][Full Text] [Related]
6. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
Wilczyński M; Dzivgielewski K
Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
[TBL] [Abstract][Full Text] [Related]
7. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
[TBL] [Abstract][Full Text] [Related]
8. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.
Cahill MT; Stinnett SS; Banks AD; Freedman SF; Toth CA
Ophthalmology; 2005 Jan; 112(1):144-51. PubMed ID: 15629835
[TBL] [Abstract][Full Text] [Related]
9. Binocular indirect panretinal laser photocoagulation for the treatment of proliferative diabetic retinopathy.
Gurelik G; Coney JM; Zakov ZN
Ophthalmic Surg Lasers Imaging; 2004; 35(2):94-102. PubMed ID: 15088818
[TBL] [Abstract][Full Text] [Related]
10. Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
Schmidinger G; Maar N; Bolz M; Scholda C; Schmidt-Erfurth U
Acta Ophthalmol; 2011 Feb; 89(1):76-81. PubMed ID: 21272288
[TBL] [Abstract][Full Text] [Related]
11. [Comparative use of diode and argon laser for panretinal photocoagulation in diabetic retinopathy].
Ulbig MW; Hamilton AM
Ophthalmologe; 1993 Oct; 90(5):457-62. PubMed ID: 8219631
[TBL] [Abstract][Full Text] [Related]
12. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study.
Muqit MM; Marcellino GR; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE
Arch Ophthalmol; 2010 May; 128(5):525-33. PubMed ID: 20457972
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy.
Mason JO; Yunker JJ; Vail R; McGwin G
Retina; 2008 Oct; 28(9):1319-24. PubMed ID: 18667958
[TBL] [Abstract][Full Text] [Related]
14. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.
Filho JA; Messias A; Almeida FP; Ribeiro JA; Costa RA; Scott IU; Jorge R
Acta Ophthalmol; 2011 Nov; 89(7):e567-72. PubMed ID: 21726427
[TBL] [Abstract][Full Text] [Related]
15. Vision-Related Quality of Life and Treatment Satisfaction Following Panretinal Photocoagulation in Diabetic Retinopathy-A Panel Study.
Vasilijević JB; Kovačević IM; Bukumirić ZM; Marić GD; Slijepčević NA; Pekmezović TD
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556943
[No Abstract] [Full Text] [Related]
16. The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER.
Broman AT; Munoz B; Rodriguez J; Sanchez R; Quigley HA; Klein R; Snyder R; West SK
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3393-8. PubMed ID: 12407148
[TBL] [Abstract][Full Text] [Related]
17. Visual prognosis after panretinal photocoagulation for proliferative diabetic retinopathy.
Bek T; Erlandsen M
Acta Ophthalmol Scand; 2006 Feb; 84(1):16-20. PubMed ID: 16445434
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy.
Ernst BJ; García-Aguirre G; Oliver SC; Olson JL; Mandava N; Quiroz-Mercado H
Acta Ophthalmol; 2012 Nov; 90(7):e573-4. PubMed ID: 22405048
[No Abstract] [Full Text] [Related]
19. Clinical efficacy of navigated panretinal photocoagulation in proliferative diabetic retinopathy.
Chhablani J; Sambhana S; Mathai A; Gupta V; Arevalo JF; Kozak I
Am J Ophthalmol; 2015 May; 159(5):884-9. PubMed ID: 25703478
[TBL] [Abstract][Full Text] [Related]
20. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
Shimura M; Yasuda K; Shiono T
Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
